Optimizing Transition of Care in Multiple Myeloma: Bridging the Gap Between Academic and Community Settings : Episode 7
Educating Patients on Complications Associated with CAR T-Cell Therapy
The panel provides clinical insights on talking with patients about complications associated with CAR T-cell therapy.
- Dr Park: What protocols and processes do you have in place at the community practice to continue monitoring and managing potential long-term complications or adverse events associated with CAR T-cell therapy?
- How do you approach monitoring for and managing late-onset neurotoxicity or other long-term adverse effects that may occur after the patient transitions back to the community setting?
Recent Videos
Related Content
